Company intelligence / Profile preview

Ortho Clinical Diagnostics

Raritan, New Jersey, United Statesextqa.orthoclinicaldiagnostics.com ↗

Ownership: Public · QDEL
Employees: ~4200
Development stage: Commercial

Overview

Ortho Clinical Diagnostics was a global leader in in vitro diagnostic solutions for hospitals, laboratories, and blood banks. The company developed automated systems and assays for immunohematology and clinical chemistry. Its innovations include the first FDA-approved automated random access hepatitis tests and early high-volume COVID‑19 antibody/antigen tests. Its products are widely used worldwide to improve efficiency and accuracy in laboratory medicine.

Therapeutic areas: OtherInfectious DiseasesCardiovascularHematology
Modalities: DeviceDiagnostic reagentImmunoassayMolecular diagnostics system
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Ortho Clinical Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ortho Clinical Diagnostics.

Explore the full profile